Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495014 | SCV000578673 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Ambry Genetics | RCV000215235 | SCV000275167 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000215235 | SCV000914019 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001478902 | SCV001683179 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-04-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001560039 | SCV001782371 | likely benign | not provided | 2021-01-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000495014 | SCV004845125 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2023-06-28 | criteria provided, single submitter | clinical testing |